ArticleNature2026
Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
43 authors.
Giannicola GenoveseDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ggenovese@mdanderson.org.
Alessandro Carugo *Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
James Tepper *Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Frederick Scott Robinson *Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Liren Li *Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Maria SveltoDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Luigi NeziDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Denise CortiDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rosalba MinelliDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Piergiorgio PettazzoniDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tony GutschnerDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Chia-Chin WuDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sahil SethDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kadir Caner AkdemirDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Elisabetta LeoInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Samirkumar AminDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Marco Dal MolinDepartment of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, Maryland, USA.
Haoqiang YingDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lawrence N KwongDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Simona CollaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Koichi TakahashiDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Papia GhoshOffice of Technology Commercialization, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Virginia GiulianiInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Florian MullerDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Prasenjit DeyDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Shan JiangDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jill GarveyInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Chang-Gong LiuDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jianhua ZhangInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Timothy P HeffernanInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Carlo ToniattiORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jason B FlemingDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Michael G GogginsDepartment of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, Maryland, USA.
Laura D WoodDepartment of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, Maryland, USA.
Alessandro SgambatoIstituto di Patologia Generale, Universitá Cattolica del Sacro Cuore, Roma, Italy.
Abbas AgaimyDepartment of Pathology, Friedrich Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany.
Anirban MaitraDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Charles W M RobertsComprehensive Cancer Center and Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Huamin WangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Andrea VialeDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ronald A DePinhoDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Giulio F DraettaDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. gdraetta@mdanderson.org.
Lynda ChinDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. lchin@mdanderson.org.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
42608482What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.